Tower Partners With Sedgwick
The new partnership means Tower will have access to additional support from Sedgwick's loss adjusters across New Zealand and the Pacific. External loss adjusters are typically used in the insurance industry for continuity of service in times of increased demand, for example, during stormy weather.
Tower Chief Claims Officer Steve Wilson says, 'As a forward-thinking insurer, we are thrilled to partner with Sedgwick to help ensure we continue to be there for our customers, no matter what.'
'The Tower team will still be with you every step of the way to progress and settle your claim. This partnership means we can assess damage and start the claims process faster during claims peaks, with more loss adjusting resource ready to go, if needed.'
The new partnership will benefit all Tower customers throughout New Zealand and the Pacific, including in smaller locations where Tower may not have a large in-region assessing or loss adjusting team.
The increased assessing resource also means specialist Tower assessors are focused on handling more complex claims.
Sedgwick New Zealand CEO Philip van Zyl says, 'We're delighted to support Tower, as a trusted Kiwi business that shares our commitment to helping communities rebuild after a loss. Through this partnership, we will combine our strengths and expertise to drive better outcomes for all stakeholders. It is about making recovery smoother, more accessible, and more effective for everyone impacted.'
About Tower
Born and bred in New Zealand, Tower has been supporting Kiwis when they need it most for more than 155 years. In that time, we've grown to operate across New Zealand and the Pacific islands, providing our customers with cover for their houses, cars, contents, businesses and more.
While our heritage is important to us, we've also set our sights on the future. Tower's focus on innovation and investment in large-scale digital transformation has enabled the business to evolve rapidly, in-line with the latest in technology and customer expectations. The result is customer-focused, digital-first insurance solutions - combined with joining forces with like minded partners, Tower has been able to create more, simpler products, to suit the modern lifestyles of its customers.
For more information, see www.tower.co.nz/
About Sedgwick
Sedgwick is the world's leading risk and claims administration partner, helping clients thrive by navigating the unexpected. The company's expertise, combined with the most advanced AI-enabled technology available, sets the standard for solutions in claims administration, loss adjusting, benefits administration and product recall. With over 33,000 colleagues and 10,000 clients across 80 countries, Sedgwick provides unmatched perspective, caring that counts, and solutions for the rapidly changing and complex risk landscape. Sedgwick's majority shareholder is The Carlyle Group; Stone Point Capital LLC, Altas Partners, CDPQ, Onex and other management investors are minority shareholders.
For more information, see sedgwick.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
2 hours ago
- NZ Herald
New Zealand sharemarket dips as F&P Healthcare, Infratil shares fall
New Zealand's largest stock, Fisher & Paykel Healthcare, fell for a second day after it hosted an investor day in Melbourne, although Goodson said there was no real news for Kiwi investors. F&P shares fell 28c to $36.41, after 328,025 shares changed hands, worth $11,918,976.27. Meanwhile, Infratil shares fell 2.45% to $11.17. 'The other key name in the index was down. In the Australian close last night Infratil entered the ASX 200 index, so buying in anticipation of that may now be absent and that could perhaps explain that decline,' Goodson said. Elsewhere, Sky TV continued its positive momentum following the news it had agreed to purchase TV3 for $1 on a cash-free, debt-free basis. Today, analysts at fund manager Octagon said the business will be worth 35c per share to its new owner – or just over $48m. Sky TV's share price climbed 6c to $3.12. 'It's hardly operating in growth markets. By bolting on a business like that and hopefully extracting some cost and revenue synergies in the future, they may be able to stem some of the structural pressures that they face,' Goodson said. He also pointed out the Colonial Motor Company, one of New Zealand's longest-listed companies. It had $125,212.55 worth of shares trade on light volume. The business, which owns a number of Ford dealerships and franchises around the country, released a guidance upgrade to its second-half results, saying it is shaping to contribute to a more positive outcome for the full-year trading profit after tax than was anticipated in February. 'It's not a reflection of the overall economic environment, rather pockets of the wider vehicle market. I think it's pointing to what's becoming fairly clear in this economy, which is that large parts of the rural sector are having a pretty good year or two, but that's yet filtering through to town,' Goodson said. Global markets The Nasdaq retreated from a record Tuesday on a mixed day for stocks as markets looked ahead to upcoming earnings reports from Google parent Alphabet and Tesla. The two reports on Wednesday are the first of Wall Street's 'Magnificent Seven' equities to report this season. The group was mixed, with drops in Nvidia and other semiconductor equities consistent with profit-taking after earlier gains, analysts said. The tech-rich Nasdaq fell 0.4% to 20,892.69, snapping a six-day streak of record high finishes. But the broad-based S&P 500 edged up 0.1% to 6309.62, finishing at a record, while the Dow Jones Industrial Average climbed 0.4% to 44,502.44. Art Hogan of B. Riley Wealth Management described the market as in a 'wait-and-see' mode ahead of earnings from the most influential equities. – Additional reporting AFP Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
NZ Herald
2 hours ago
- NZ Herald
Helius and Elysian to continue merger after Cannabis Clinic withdrawal
'I think these things happen when you're looking at mergers and going through that process, you get to learn more about how the entire structure would work, about each other's cultures and how we approach things, we understand more about each other's businesses as well,' Alzaher said. 'That's why we mutually agreed and reached the conclusion that it would be better for us to work independently.' Dr Waseem Alzaher, CEO and co-founder of the Cannabis Clinic, says it will be better for the businesses to work independently towards their shared goal. Alzaher said the proposal had been spoken about between the parties for about two months before the announcement to the public. After a further three weeks deep-diving on the proposal and deciding on how it would work, the decision was made for it not to proceed. Alzaher said the decision to communicate proactively about the proposal was because of Helius Therapeutics' shareholders and its responsibility to keep them involved, and he said he would do the process the same if given another opportunity. 'We're still open to partnerships, to collaboration, to investment, to coming together, so that one plus one equals 10. 'The bigger picture for us is revolutionising healthcare, how healthcare is delivered, the systems, the expectations, how it's centred around people. 'That's a big mission. Our big area audacious goal is to have a million long-term clients with us, and that's not going to happen overnight.' As for what didn't work between Cannabis Clinic and Helius Therapeutics, Alzaher said that their business cultures and visions were not necessarily aligned. He viewed Cannabis Clinic as a 'rebel' and a 'misfit' trying to disrupt the system, and said the business' time could be better spent helping more Kiwis instead. Alzaher said he could see the businesses working together in the future, although not in the 'foreseeable future'. 'With Helius they've got products that are New Zealand made and we're still distributing them. We see them as a strategic partner for us moving forward. 'They believe in what we're doing, we believe in what they're doing, and we're still talking to each other and on good terms.' Helius Health chairman Guy Haddleton previously said the industry long needed a reset. Photo / File Merger moves on Despite the mutual decision for Cannabis Clinic to pull out of the proposed merger, Helius Therapeutics and Elsyian Group/CannaPlus have confirmed a two-way merger will now take its place. Helius Therapeutics financial officer Bruce McEwen said the businesses expect to settle in August. 'What happens now – it's full steam ahead with the execution of the new strategy and the merger with CannaPlus," McEwen said. 'Whilst it's now a two not three-way merger and reduces overall scale, it doesn't change the direction or effectiveness of the strategy. It does however make it simpler, enabling us to move faster.' McEwen said Helius Therapeutics shareholders were firmly behind the strategy pivot to vertically integrate and the proposed two-party merger. He said Helius Therapeutics and Cannabis Clinic had a strong mutual respect for each other and continued to be key business partners. 'After careful consideration we mutually agreed not to proceed with the proposed merger between Helius Therapeutics and Cannabis Clinic. 'Whilst there is strong alignment around increasing access to medicinal cannabis and reducing the stigma, we agreed that was better achieved independently.' Helius Health chairman Guy Haddleton was unavailable for comment. Elysian executive chairwoman Eva Piëch said the fundamentals of the transaction remained intact. 'The transition to a two-party merger between Elysian and Helius is a deliberate and strategically focused decision. It enhances clarity, accelerates execution, and strengthens alignment – not only operationally, but philosophically,' Piëch said. 'This structure allows for faster execution, clearer governance and greater strategic clarity. Our infrastructure, patient network and digital platform remain core to the combined strategy.' Piëch said that as discussions matured with Cannabis Clinic, it became clear a three-party integration would introduce operational complexity and dilute strategic focus – without materially strengthening the core proposition. She said the two-party plan would preserve strategic coherence and allow the pair to integrate with speed, purpose and precision. 'This two-way merger creates a clean, tightly aligned platform – one that enables rapid integration, strategic coherence and a stronger foundation for long-term innovation and growth.' Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
NZ Herald
4 hours ago
- NZ Herald
Watch: Fonterra boss points finger at international prices and supermarkets in butter meeting with Wills
When asked whether anything raised in the meeting would lead to lower prices, Willis said, 'All roads lead back to supermarket competition.' 'I continue to believe that is the most powerful lever the Government has on this issue. We will never be able to control global dairy prices, but we can influence the amount of competition in New Zealand's grocery sector,' Willis said. Willis said she had three main reflections on her conversation, the first was that 'the large proportion of the price of butter at the supermarket is dictated by global demand for butter'. 'There's a story to tell there: butter, which was once an unfashionable product, has gone into huge demand globally and that's reflected in the price people are willing to pay for it internationally,' she said. She had been told by Hurrell that when the global dairy price comes down, butter prices in New Zealand are expected to come down too. She added that high prices had a positive upside. 'It's worth noting that when the price is high that is hundreds of millions of dollars of export revenue coming into our country,' Willis said. The second issue raised was retailers. 'What Miles acknowledged, and what every New Zealander can see, is that supermarkets make choices about what margin they charge for butter. Now this is at the margin, it is a small proportion of the overall price that you pay, between 5% and 10% of the overall price shared between Fonterra and the retailer. 'What is clear is that different retailers make different decisions about what margins they charge,' Willis said. Willis, who once worked for Fonterra, revealed the fact she was meeting Hurrell last week. While the meeting was already scheduled, she let it be known she planned to raise the cost of butter with him. The third point raised by Hurrell was that the dairy giant was itself squeezing costs out of the system to ensure prices could be lower for shoppers. On Wednesday, she expressed regret that the significance of the meeting had spiralled out of proportion. 'I've been very surprised at the almost breathless excitement of the blow by blow of what happened in that meeting,' Willis said. It is not clear what, if anything, Fonterra could do to lower the cost of butter, given the main driver of the price Kiwis pay is the price our dairy fetches on the international commodities market. Willis praised the success of these exporters in Parliament on Wednesday, noting exporters, including dairy, are delivering an export-led economic recovery.
